Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Safani

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Seminars in Thrombosis and Hemostasis|July 10, 2023
Greats in the History of Thrombosis and HemostasisMichael Safani
Current Medical Research and Opinion|November 13, 2004
Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial diseaseJeffrey J Cavendish, Michael Safani
Journal of Electrocardiology|March 11, 2008
Coexistent manifestations of the Andersen-Tawil and Brugada syndromesAdrian H Shandling, Michael Safani
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 31, 2015
When to re-dose regadenoson?Gregory S Thomas, Aaron F Jolly, Michael Safani
Current Medical Research and Opinion|November 13, 2004
Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromesJeffrey J Cavendish, Randolph V Fugit, Michael Safani
Chest|May 10, 2017
Average-Weight Methodology in Weight-Based Unfractionated Heparin Therapy in the Presence of ObesityMichael Safani, Serge Tobias, Michele Robinson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 22, 2018
Unfractionated Heparin Protocol During Percutaneous Left Ventricular Mechanical Circulatory (Impella) SupportMichelle Christina Lee, Cindy Peters, Neepa Rai, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2021
Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation of Atrial Fibrillation in the Presence of Direct Oral Anticoagulants and Wide Spectrum of Body Mass IndexMichael Safani, Serge Tobias, Adrian H Shandling, et al.
Expert Review of Hematology|January 13, 2023
Application of anti-Xa assay in monitoring unfractionated heparin therapy in contemporary antithrombotic managementMichael Safani, Steve Appleby, Ryan Chiu, et al.
Chest|June 5, 2013
The use of average body weight in dosing unfractionated heparinMichael Safani, Stanley E Hill, Rex Winters, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Thrombosis and Hemostasis|July 10, 2023
Greats in the History of Thrombosis and HemostasisMichael Safani
Current Medical Research and Opinion|November 13, 2004
Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial diseaseJeffrey J Cavendish, Michael Safani
Journal of Electrocardiology|March 11, 2008
Coexistent manifestations of the Andersen-Tawil and Brugada syndromesAdrian H Shandling, Michael Safani
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 31, 2015
When to re-dose regadenoson?Gregory S Thomas, Aaron F Jolly, Michael Safani
Current Medical Research and Opinion|November 13, 2004
Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromesJeffrey J Cavendish, Randolph V Fugit, Michael Safani
Chest|May 10, 2017
Average-Weight Methodology in Weight-Based Unfractionated Heparin Therapy in the Presence of ObesityMichael Safani, Serge Tobias, Michele Robinson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 22, 2018
Unfractionated Heparin Protocol During Percutaneous Left Ventricular Mechanical Circulatory (Impella) SupportMichelle Christina Lee, Cindy Peters, Neepa Rai, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2021
Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation of Atrial Fibrillation in the Presence of Direct Oral Anticoagulants and Wide Spectrum of Body Mass IndexMichael Safani, Serge Tobias, Adrian H Shandling, et al.
Expert Review of Hematology|January 13, 2023
Application of anti-Xa assay in monitoring unfractionated heparin therapy in contemporary antithrombotic managementMichael Safani, Steve Appleby, Ryan Chiu, et al.
Chest|June 5, 2013
The use of average body weight in dosing unfractionated heparinMichael Safani, Stanley E Hill, Rex Winters, et al.
Pageof 2